Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176625812> ?p ?o ?g. }
- W3176625812 endingPage "526" @default.
- W3176625812 startingPage "526" @default.
- W3176625812 abstract "In the era of novel coronavirus epidemics, vaccines against coronavirus disease 2019 (COVID-19) have been recognized as the most effective public health interventions to control the pandemic. An adverse event following immunization (AEFI) is defined as any untoward occurrence following immunization, and the majority of AEFIs are caused by protective immune responses stimulated by vaccines. Most of the reported AEFIs are not serious, and many are not immunologically mediated or even reproducible on re-exposure. However, uncommon severe allergic adverse reactions, such as anaphylaxis or other allergic reactions, can occur after vaccinations. Confirmed allergic reactions to vaccines may be caused by residual non-human protein, preservatives, or stabilizers in the vaccine formulation (also known as excipients). There are 2 main potential allergenic/immunogenic excipients in COVID-19 vaccines, polyethylene glycol (PEG) and polysorbate 80. PEG, also known as macrogol, is an ingredient in various laxatives and injectable formulations, such as depot steroids. Polysorbate 80 is present in various medical products, creams, ointments, lotions, and medication tablets. Contraindications to the administration of COVID-19 vaccines include a previous history of severe allergic reactions to the first dose of COVID-19 vaccine or proven hypersensitivity to a vaccine component, such as PEG or polysorbate 80. Anaphylaxis or other allergic reactions following immunization can cause fear and loss of confidence in the safety of vaccines among the public. A better understanding of these events is thought to help alleviate concerns about the current COVID-19 vaccines and provide reassurance to the general population by analyzing the exact incidence of anaphylaxis and potential risk factors. COVID-19 vaccine-associated anaphylaxis could be prevented and managed by risk stratification based on our local and global experience." @default.
- W3176625812 created "2021-07-05" @default.
- W3176625812 creator A5003824244 @default.
- W3176625812 creator A5016241392 @default.
- W3176625812 creator A5028254571 @default.
- W3176625812 creator A5038852974 @default.
- W3176625812 creator A5040488465 @default.
- W3176625812 creator A5042117032 @default.
- W3176625812 creator A5052288891 @default.
- W3176625812 creator A5064660827 @default.
- W3176625812 creator A5066538135 @default.
- W3176625812 creator A5073854525 @default.
- W3176625812 creator A5080835850 @default.
- W3176625812 creator A5088167495 @default.
- W3176625812 creator A5091474946 @default.
- W3176625812 date "2021-01-01" @default.
- W3176625812 modified "2023-10-17" @default.
- W3176625812 title "COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group" @default.
- W3176625812 cites W1964339933 @default.
- W3176625812 cites W1965883759 @default.
- W3176625812 cites W2101621873 @default.
- W3176625812 cites W2118732577 @default.
- W3176625812 cites W2206915812 @default.
- W3176625812 cites W2408672205 @default.
- W3176625812 cites W2572373405 @default.
- W3176625812 cites W2800173383 @default.
- W3176625812 cites W2890837084 @default.
- W3176625812 cites W2894673622 @default.
- W3176625812 cites W2904228061 @default.
- W3176625812 cites W2910917044 @default.
- W3176625812 cites W2970922758 @default.
- W3176625812 cites W3001375137 @default.
- W3176625812 cites W3042833857 @default.
- W3176625812 cites W3081892744 @default.
- W3176625812 cites W3089962069 @default.
- W3176625812 cites W3097625054 @default.
- W3176625812 cites W3101925386 @default.
- W3176625812 cites W3111255098 @default.
- W3176625812 cites W3111590711 @default.
- W3176625812 cites W3112041782 @default.
- W3176625812 cites W3114586947 @default.
- W3176625812 cites W3119345685 @default.
- W3176625812 cites W3119550995 @default.
- W3176625812 cites W3120193730 @default.
- W3176625812 cites W3120927170 @default.
- W3176625812 cites W3120968995 @default.
- W3176625812 cites W3122447288 @default.
- W3176625812 cites W3125874619 @default.
- W3176625812 cites W3126257938 @default.
- W3176625812 cites W3126621205 @default.
- W3176625812 cites W3126795547 @default.
- W3176625812 cites W3128551684 @default.
- W3176625812 cites W3130815000 @default.
- W3176625812 cites W3134831990 @default.
- W3176625812 cites W3135409975 @default.
- W3176625812 cites W3147435343 @default.
- W3176625812 cites W3154615775 @default.
- W3176625812 cites W3156698571 @default.
- W3176625812 cites W4205483821 @default.
- W3176625812 cites W4211216304 @default.
- W3176625812 cites W949516480 @default.
- W3176625812 doi "https://doi.org/10.4168/aair.2021.13.4.526" @default.
- W3176625812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8255352" @default.
- W3176625812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34212542" @default.
- W3176625812 hasPublicationYear "2021" @default.
- W3176625812 type Work @default.
- W3176625812 sameAs 3176625812 @default.
- W3176625812 citedByCount "51" @default.
- W3176625812 countsByYear W31766258122021 @default.
- W3176625812 countsByYear W31766258122022 @default.
- W3176625812 countsByYear W31766258122023 @default.
- W3176625812 crossrefType "journal-article" @default.
- W3176625812 hasAuthorship W3176625812A5003824244 @default.
- W3176625812 hasAuthorship W3176625812A5016241392 @default.
- W3176625812 hasAuthorship W3176625812A5028254571 @default.
- W3176625812 hasAuthorship W3176625812A5038852974 @default.
- W3176625812 hasAuthorship W3176625812A5040488465 @default.
- W3176625812 hasAuthorship W3176625812A5042117032 @default.
- W3176625812 hasAuthorship W3176625812A5052288891 @default.
- W3176625812 hasAuthorship W3176625812A5064660827 @default.
- W3176625812 hasAuthorship W3176625812A5066538135 @default.
- W3176625812 hasAuthorship W3176625812A5073854525 @default.
- W3176625812 hasAuthorship W3176625812A5080835850 @default.
- W3176625812 hasAuthorship W3176625812A5088167495 @default.
- W3176625812 hasAuthorship W3176625812A5091474946 @default.
- W3176625812 hasBestOaLocation W31766258121 @default.
- W3176625812 hasConcept C126322002 @default.
- W3176625812 hasConcept C16005928 @default.
- W3176625812 hasConcept C203014093 @default.
- W3176625812 hasConcept C207480886 @default.
- W3176625812 hasConcept C2775933838 @default.
- W3176625812 hasConcept C2777995640 @default.
- W3176625812 hasConcept C2779134260 @default.
- W3176625812 hasConcept C3008058167 @default.
- W3176625812 hasConcept C524204448 @default.
- W3176625812 hasConcept C71924100 @default.
- W3176625812 hasConceptScore W3176625812C126322002 @default.
- W3176625812 hasConceptScore W3176625812C16005928 @default.